보형물연관 역형성대세포림프종 BIA-ALCL

[BACKGROUND/OBJECTIVE] Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) has affected more than 1700 women with textured breast implants. About 80% of patients present with fluid (seroma) around their implant. BIA-ALCL can…

Anaplastic large cell lymphoma (ALCL) cases were discussed at the 2023 Society of Hematopathology/European Association for Haematopathology workshop held on November 9-11, 2023, in Houston, Texas. This session focused on the clinical and pa…

Level of Evidence V This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors …

[INTRODUCTION] Breast implants consist of a silicone elastomer shell filled with either silicone gel or saline solution. As per the Food and Drug Administration (FDA), breast implants offer safety and efficacy but pose short and long-term r…

Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) is a rare CD-30+/ALK- T-cell lymphoma. The combination of a textured breast implant, bacterial contamination and genetic predisposition appears to be necessary for the deve…

[BACKGROUND] Silimed silicone gel polyurethane (PU) foam-covered breast implants are used worldwide. There is extensive clinical experience with the long-term use of these implants, but scientific evidence on this topic remains limited. Thi…

Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) is a rare T-cell non-Hodgkin lymphoma, representing less than 1% of breast neoplasms. Despite its low incidence, the increasing number of women with breast implants necessi…

Anaplastic Large Cell Lymphoma (ALCL) represents a diverse group of mature T-Cell Lymphomas unified by strong CD30 expression but with different molecular and clinical subtypes. This review summarizes recent molecular advances in ALCL, high…

Over the past 20 years, breast augmentation has become increasingly popular for enhancing breast size and correcting asymmetry. Saline implants were initially used, followed by silicone implants and autologous fat transfer. However, complic…

: One of the most controversial issues in contemporary plastic surgery is the potential association between textured breast implants and breast implant-associated anaplastic large cell lymphoma (BIA-ALCL). Despite growing concern, the safet…

[OBJECTIVE] Peri-implant enhancement can be seen on contrast-enhanced breast MRI, but its association with malignancy has not been described, leading to considerable variability in assessment and recommendations by radiologists. This study …

Breast cancer presents unique complexities for transgender individuals. This retrospective study characterized breast cancers in 14 transgender and nonbinary patients treated at a specialized transgender health center from 2016 to 2023. Pat…

[BACKGROUND] Psychological factors seem to play a significant role in the perception and magnification of somatic symptoms in patients with breast implant illness (BII). Further, recent studies have shown that some patients with self-report…

[BACKGROUND] Assessment of breast implant-associated anaplastic large-cell lymphoma (BIA-ALCL) prevalence is challenged by a lack of population-level data for the prevalence of breast implants in the wider population. Absence of such data o…

: The voluntary recall and ban of several textured breast implant models worldwide, secondary to their association with Breast Implant-Associated Anaplastic Large Cell Lymphoma, has limited the key benefit of a textured surface─positional s…

[BACKGROUND] Accurate estimation of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL) incidence is crucial for assessing breast-implant-associated risk. However, the size of the implanted population worldwide is unknown, m…